Free Trial

Arbutus Biopharma (ABUS) Institutional Ownership

Arbutus Biopharma logo
$4.44 -0.01 (-0.11%)
As of 10:09 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

Current
Institutional Ownership
Percentage
43.79%
Number of
Institutional Buyers
(last 12 months)
85
Total
Institutional Inflows
(last 12 months)
$372.82M
Number of
Institutional Sellers
(last 12 months)
40
Total
Institutional Outflows
(last 12 months)
$37.63M
Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Squarepoint Ops LLC208,145$999K0.0%N/A0.105%
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al41,800$201K0.0%N/A0.021%
8/22/2026Premier Path Wealth Partners LLC30,000$144K0.0%-25.0%0.015%
8/21/2026AXQ Capital LP25,055$120K0.0%N/A0.013%
8/20/2026Two Sigma Securities LLC23,470$113K0.0%N/A0.012%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC261,052$1.25M0.0%-68.9%0.132%
8/19/2026Wellington Management Group LLP461,646$2.22M0.0%+4.7%0.233%
8/18/2026Jefferies Financial Group Inc.1,711,672$8.22M0.1%N/A0.865%
8/17/2026Bank of America Corp DE2,646,197$12.70M0.0%N/A1.337%
8/15/2026Man Group plc473,467$2.27M0.0%N/A0.240%
8/15/2026Jupiter Topco LLC597,423$2.87M0.0%N/A0.302%
8/14/2026ADAR1 Capital Management LLC1,268,147$6.09M0.3%N/A0.642%
8/14/2026Whitefort Capital Management LP15,794,261$75.81M0.0%N/A7.995%
8/14/2026Legal & General Group Plc2,466,127$11.84M0.0%N/A1.248%
8/14/2026The Manufacturers Life Insurance Company44,305$213K0.0%N/A0.022%
8/13/2026Connor Clark & Lunn Investment Management Ltd.130,023$624K0.0%N/A0.066%
8/13/2026Two Seas Capital LP19,095,583$91.66M1.8%N/A9.667%
8/13/2026Clear Harbor Asset Management LLC27,000$130K0.0%N/A0.014%
8/11/2026E Fund Management Co. Ltd.14,406$69K0.0%N/A0.007%
8/11/2026Western Standard LLC542,787$2.61M0.9%N/A0.275%
8/7/2026BlackRock Inc.13,766,071$66.08M0.0%N/A6.969%
8/7/2026Deutsche Bank AG170,454$818K0.0%N/A0.086%
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.53,320$256K0.0%N/A0.027%
8/7/2026Cura Wealth Advisors LLC15,000$72K0.0%N/A0.008%
8/6/2026Bank of New York Mellon Corp454,115$2.18M0.0%N/A0.230%
8/6/2026GSA Capital Partners LLP44,082$212K0.0%N/A0.022%
8/6/2026Stoneridge Investment Partners LLC10,125$44K0.0%N/A0.005%
8/3/2026Walleye Trading LLC14,000$67K0.0%N/A0.007%
5/28/2026Avidity Partners Management LP125,000$562K0.1%N/A0.063%
5/19/2026Front Row Advisors LLC110,500$497K0.2%+952.4%0.056%
5/19/2026Bank of America Corp DE1,683,628$7.58M0.0%-8.1%0.852%
5/18/2026ADAR1 Capital Management LLC3,133,175$14.10M0.8%-42.1%1.586%
5/18/2026Rubric Capital Management LP6,626,389$29.82M0.3%+320.6%3.354%
5/16/2026The Manufacturers Life Insurance Company42,429$191K0.0%-10.6%0.021%
5/16/2026Quantinno Capital Management LP48,715$219K0.0%-10.9%0.025%
5/15/2026Rangeley Capital LLC500,000$2.25M2.1%-40.5%0.253%
5/14/2026Inceptionr LLC32,580$147K0.0%+14.6%0.017%
5/5/2026Bank of New York Mellon Corp379,373$1.71M0.0%-2.2%0.193%
5/4/2026Principal Financial Group Inc.10,977$49K0.0%N/A0.006%
4/28/2026Abel Hall LLC20,073$90K0.0%-34.8%0.010%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
4/16/2026SG Americas Securities LLC79,033$356K0.0%+89.8%0.040%
2/19/2026Invesco Ltd.247,254$1.19M0.0%+17.9%0.129%
2/18/2026Mercer Global Advisors Inc. ADV45,120$217K0.0%+15.8%0.023%
2/18/2026Virtus Investment Advisers LLC56,483$272K0.1%+77.7%0.029%
2/18/2026Wellington Management Group LLP474,361$2.28M0.0%-7.7%0.247%
2/18/2026Saba Capital Management L.P.347,885$1.67M0.0%-48.7%0.181%
2/18/2026Oxford Asset Management LLP21,632$104K0.0%N/A0.011%
2/18/2026Man Group plc120,821$581K0.0%+52.2%0.063%
2/18/2026Irenic Capital Management LP59,853$288K0.0%N/A0.031%
2/18/2026Balyasny Asset Management L.P.141,646$681K0.0%+31.6%0.074%
2/17/2026ADAR1 Capital Management LLC5,415,109$26.05M1.9%+86.5%2.816%
2/17/2026Abel Hall LLC30,779$148K0.0%N/A0.016%
2/17/2026Lazard Asset Management LLC67,840$326K0.0%N/A0.035%
2/17/2026Amundi11,878$57K0.0%N/A0.006%
2/17/2026Price T Rowe Associates Inc. MD89,216$430K0.0%+7.5%0.046%
2/17/2026Osaic Holdings Inc.1,348,224$6.49M0.0%+0.7%0.701%
2/17/2026Adage Capital Partners GP L.L.C.4,339,941$20.88M0.0%-13.5%2.257%
2/17/2026California State Teachers Retirement System144,110$693K0.0%+9.6%0.075%
2/17/2026State of Wisconsin Investment Board92,769$446K0.0%+621.2%0.048%
2/17/2026ExodusPoint Capital Management LP30,503$147K0.0%-63.0%0.016%
2/17/2026Royal Bank of Canada65,687$316K0.0%-72.3%0.034%
2/16/2026Squarepoint Ops LLC28,775$138K0.0%-57.4%0.015%
2/16/2026Verition Fund Management LLC20,000$96K0.0%N/A0.010%
2/16/2026Barclays PLC356,684$1.72M0.0%+25.4%0.185%
2/13/2026The Manufacturers Life Insurance Company 47,459$228K0.0%-12.4%0.025%
2/13/2026Hudson Bay Capital Management LP675,000$3.25M0.0%-15.6%0.351%
2/13/2026Morgan Stanley26,702,776$128.44M0.0%+9.2%13.885%
2/13/2026Rafferty Asset Management LLC117,032$563K0.0%+120.8%0.061%
2/13/2026Charles Schwab Investment Management Inc.1,562,265$7.51M0.0%+22.5%0.812%
2/13/2026State Street Corp5,908,211$28.42M0.0%+44.2%3.072%
2/13/2026Dynamic Technology Lab Private Ltd25,779$124K0.0%N/A0.013%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC890,898$4.29M0.0%N/A0.463%
2/13/2026Wells Fargo & Company MN167,021$803K0.0%+75.0%0.087%
2/12/2026MetLife Investment Management LLC73,236$352K0.0%-16.6%0.038%
2/12/2026Cibc World Markets Corp10,015$48K0.0%N/A0.005%
2/12/2026EntryPoint Capital LLC75,607$364K0.1%+161.9%0.039%
2/12/2026Ensign Peak Advisors Inc27,600$133K0.0%-38.7%0.014%
2/12/2026AlphaCentric Advisors LLC47,925$231K0.2%N/A0.025%
2/12/2026Campbell & CO Investment Adviser LLC113,113$544K0.0%+54.3%0.059%
2/12/2026Swiss National Bank283,400$1.36M0.0%+2.6%0.147%
2/11/2026Inceptionr LLC28,418$137K0.0%N/A0.015%
2/11/2026T3 Companies LLC34,000$164K0.2%N/A0.018%
2/11/2026Deutsche Bank AG140,198$674K0.0%+6.4%0.073%
2/11/2026Los Angeles Capital Management LLC46,520$225K0.0%N/A0.024%
2/11/2026Two Seas Capital LP12,589,158$60.55M1.2%+14.5%6.546%
2/11/2026State of Wyoming15,421$74K0.0%N/A0.008%
2/10/2026CIBC Asset Management Inc14,382$69K0.0%N/A0.007%
2/10/2026Goldman Sachs Group Inc.738,580$3.55M0.0%-66.0%0.384%
2/10/2026Intech Investment Management LLC70,563$339K0.0%+48.6%0.037%
2/9/2026Geode Capital Management LLC3,677,307$17.69M0.0%+0.3%1.912%
They didn't warn anyone in 1971. This time someone is warning you. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
2/6/2026ProShare Advisors LLC36,161$174K0.0%+10.5%0.019%
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.54,066$258K0.0%-26.6%0.028%
2/3/2026SBI Securities Co. Ltd.29,625$142K0.0%-31.0%0.015%
1/28/2026Arizona State Retirement System39,962$192K0.0%-5.7%0.021%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank128,315$617K0.0%+27.9%0.067%
1/26/2026PFG Investments LLC11,000$53K0.0%-18.5%0.006%
1/20/2026Wealth Management Associates Inc.127,870$615K0.2%+13.3%0.066%
1/9/2026SG Americas Securities LLC41,638$200K0.0%+78.1%0.022%
1/1/2026JPMorgan Chase & Co.98,229$446K0.0%+14.1%0.051%
12/15/2025Hudson Bay Capital Management LP800,000$3.63M0.0%-17.1%0.416%


ABUS Institutional Ownership - Frequently Asked Questions

During the previous two years, 144 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Morgan Stanley ($128.44M), Two Seas Capital LP ($91.66M), Whitefort Capital Management LP ($75.81M), BlackRock Inc. ($66.08M), Vanguard Group Inc. ($40.82M), Rubric Capital Management LP ($29.82M), and State Street Corp ($28.42M).Learn more on Arbutus Biopharma's institutional investors.

43.79% of Arbutus Biopharma's stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.

Of the 126 institutional investors that purchased Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Two Seas Capital LP ($23.65M), Whitefort Capital Management LP ($16.17M), BlackRock Inc. ($13.77M), Rubric Capital Management LP ($5.05M), ADAR1 Capital Management LLC ($4.18M), Bank of America Corp DE ($3.81M), and State Street Corp ($3.28M).

Institutional investors have bought a total of 78,127,437 shares in the last 24 months. This purchase volume represents approximately $372.82M in transactions.

Of the 40 institutional investors that sold Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($2.28M), Goldman Sachs Group Inc. ($1.43M), Adage Capital Partners GP L.L.C. ($675K), Foursixthree Capital LP ($578.39K), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($577.16K), Rangeley Capital LLC ($340K), and Woodline Partners LP ($332.38K).

Institutional investors have sold a total of 8,103,725 shares in the last 24 months. This volume of shares sold represents approximately $37.63M in transactions.



Institutional ownership data for NASDAQ:ABUS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners